Auris Medical Holding Ltd. Skyrocketed
Tue, Mar 09, 2021 at 05:33 PM
Auris Medical Holding Ltd. (EARS:NASDAQ) shot up at $5.2, a gain of 52%. On Mon 08 Mar 21, EARS:NASDAQ touched a New 2-Week Intraday High of $4.2. From Mon 22 Feb 21, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Fri 19 Feb 21 at $5.54 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About Auris Medical Holding Ltd. (EARS:NASDAQ)
Auris Medical Holding AG is a clinical-stage biopharmaceutical company. It is engaged in the development of novel products for the treatment of inner ear disorders. Its product candidate is AM-101.
Top 10 Gainers:
- Exela Technologies, Inc. (XELA:NASDAQ), 179.39%
- OCAX (OCAX:NASDAQ), 100%
- Washington Prime Group Inc. (WPG:NYSE), 86.26%
- Sintx Technologies, Inc. (SINT:NASDAQ), 58.56%
- Auris Medical Holding Ltd. (EARS:NASDAQ), 52.05%
- Canaan Inc. (CAN:NASDAQ), 50.45%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 49.22%
- Oragenics, Inc. (OGEN:NYSEMKT), 47.97%
- The9 Limited (NCTY:NASDAQ), 37.13%
- ReneSola Ltd (SOL:NYSE), 36.3%